top of page

BELKYRA® Double Chin Treatment

Double chin is characterized by localized fat accumulation in the submental region, making people feel older and more overweight than they actually are, and brings impact to both men and women.

Double chin maybe due to:

  • Genetics

  • Aging

  • Weight Change

The only FDA approved treatment for undesirable submental fullness 

Belkyra is a new, patented formulation of Deoxycholic Acid (DCA), which is biologically equivalent to naturally occurring molecule. 

 

Targeting submental fullness, Belkyra disrupts adipocyte membranes, leading to irreversible fat cell breakdown. 

  • Permanently destroy fat cells

  • Non-surgical procedure 

  • US FDA and EMA approved 

  • The only FDA approved treatment for undesirable submental fullness 

  • Average 2-4 treatment sessions for permanent fat cell breakdown

  • Research proven - Long-term safety study data up to 5 years 

Related Treatments:

Make an Appointment

香港銅鑼灣霎東街11-13號The Sharp 17樓A室

銅鑼灣港鐵站A出口(時代廣場後面)

香港铜锣湾霎东街11-13号The Sharp 17楼A室

铜锣湾港铁站A出口(时代广场后面)

Unit A, 17/F The Sharp,

11-13 Sharp Street East, Causeway Bay, Hong Kong

Causeway Bay MTR Exit A

 

敬請預約 ( by appointment only)

星期一至五 Mon-Fri:                      10am-7pm

星期六 Sat:                                      9:30am-5:30pm

星期日及公眾假期

Sun & public holiday:                    休息 Off​

 

Tel:                              2522 2205

WhatsApp/WeChat:  9844 2963

 

Email: medicglow@gmail.com

Find us
聯絡我們 Contact us

Thanks! Message sent.

Copyright 2023 Maxicare Limited / Medic Glow all rights reserved.

bottom of page